...
首页> 外文期刊>Nursing forum >A study of the safety of continued anticoagulation for cataract surgery patients.
【24h】

A study of the safety of continued anticoagulation for cataract surgery patients.

机译:白内障手术患者持续抗凝安全性的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Cataract surgery is the most common procedure performed on Medicare recipients. Many of these patients have been on anticoagulation therapy (ACT) regimens, but no consistent standard currently governs the use or cessation of ACT prior to surgery. This study evaluated the safety of continuing ACT in cataract surgery patients (of ASA III physical status) at seven centers. There was a 53% incidence of previous ACT among the 1,842 individuals sampled. During 2,241 procedures, only two patients (one on ACT) experienced abnormal surgical bleeding, noted as hyphemas. Seventeen (0.9%), nine on ACT and eight not on it, had some type of bleeding related to regional anesthesia; of these, nine had bruising and eight had subconjunctival hemorrhage. No major complications were noted in the ACT group during surgery, or at visits 1 day and 1 week postoperatively.
机译:白内障手术是对Medicare接受者执行的最常见手术。这些患者中有许多接受了抗凝治疗(ACT)方案,但目前尚无一致的标准来控制手术前ACT的使用或停止。这项研究评估了在七个中心(ASA III身体状态)的白内障手术患者中继续进行ACT的安全性。在1842名样本中,先前ACT的发生率为53%。在2,241例手术中,只有2例患者(ACT中1例)经历了异常的外科手术出血,称为前房积血。 17例(0.9%),ACT上9例,ACT上没有8例发生与局部麻醉有关的某种类型的出血;其中,有9例瘀伤,有8例结膜下出血。 ACT组在手术期间或术后1天和1周就诊时未发现重大并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号